MERZ THERAPEUTICS
Merz Therapeutics is dedicated to improving the lives of patients around the world with its relentless research, development, and culture of innovation. Merz Therapeutics strives to serve unmet patient needs and realize better outcomes.
Similar Organizations
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Odonate Therapeutics
Odonate Therapeutics is dedicated to the development of therapeutics that improve and extend the lives of patients with cancer.
PolyCore Therapeutics
PolyCore Therapeutics’ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-02-07 | Vensica Medical | Merz Therapeutics investment in Corporate Round - Vensica Medical | 3 M USD |
More informations about "Merz Therapeutics"
Therapeutic Innovations for our patients | Merz Therapeutics
Merz Therapeutics Broadens Specialty Neurology Portfolio. We are proud to share two new products added to the Merz Therapeutics' treatment portfolio, enhancing our offerings for …See details»
Management team | Merz Therapeutics
Get to know the people who are shaping the future of Merz Therapeutics with their experience and expertise.See details»
Merz Therapeutics and World Stroke Organization Launch ‘Access …
Oct 24, 2024 · Building on the existing efforts led by the WSO, Merz Therapeutics will offer strategic support to further develop stroke care infrastructure, specifically through the support …See details»
Merz Therapeutics - Merz Pharma
Merz Therapeutics For patients with movement disorders, botulinum neurotoxin is often the treatment of choice. Merz is proud to be among the first companies in the world to successfully …See details»
Merz Therapeutics and World Stroke Organization Launch ‘Access …
Oct 24, 2024 · FRANKFURT, Germany-- (BUSINESS WIRE)--Today, at the annual World Stroke Congress in Abu Dhabi, the President of the World Stroke Organization (WSO), Dr. Sheila …See details»
News & Press releases | Merz Therapeutics
Nov 19, 2024 · Merz Therapeutics, a business of the Merz Group and leader in the field of neurotoxins, announces the promotion of Dr. Michael Pfeil to the role of Head of Therapeutics …See details»
Merz Therapeutics and World Stroke Organization Launch
Oct 24, 2024 · FRANKFURT, Germany-- (BUSINESS WIRE)--Today, at the annual World Stroke Congress in Abu Dhabi, the President of the World Stroke Organization (WSO), Dr. Sheila …See details»
Home - Merz Pharma
110 years ago, on March 9, 1918, the pharmacist and chemist Friedrich Merz founded the Chemische Fabrik Merz & Co. in Frankfurt am Main, Germany. Today, Merz remains a family-owned company, but has evolved into a global …See details»
Merz Therapeutics and World Stroke Organization Launch ‘Access …
Oct 24, 2024 · Today, at the annual World Stroke Congress in Abu Dhabi, the President of the World Stroke Organization (WSO), Dr. Sheila Martins, officially announced a partnership with …See details»
Merz Therapeutics - LinkedIn
Merz Therapeutics | 71,549 followers on LinkedIn. Better outcomes for more patients | At Merz Therapeutics, we seek to address the unique needs of people who suffer from movement …See details»
Merz Therapeutics and S3 Connected Health Pioneer …
1 day ago · Merz Therapeutics. Merz Therapeutics GmbH is dedicated to improving the lives of patients around the world. With its relentless research, development, and culture of innovation, Merz Therapeutics strives to serve …See details»
Merz Therapeutics - Crunchbase Investor Profile & Investments
Merz Therapeutics is dedicated to improving the lives of patients around the world with its relentless research, development, and culture of innovation. Merz Therapeutics strives to …See details»
Merz enters Asset Purchase Agreement with a US-based ... - Merz …
Apr 2, 2024 · Frankfurt am Main, Germany / April 1, 2024 / Merz Therapeutics, a business of Frankfurt-based Merz Group, has entered into an Asset Purchase Agreement to acquire two …See details»
Persistent passion with focus | Merz Therapeutics - North America …
Our tightknit organization thrives in a company culture defined by community, connection and mutual support. We care about each other just as intensely as we care about our work. Open …See details»
Sustainability Report 2023 - merztherapeutics.com
MERZ THERAPEUTICS GMBH. Content CEO Letter 1. INTRODUCTION4 1.1. About Merz Therapeutics 5 1.2. Our Portfolio 6 2. OUR JOURNEY TO SUSTAINABILITY 7 2.1. Our …See details»
Merz to expand and hunt for more deals after closing Inbrija buy
Jul 11, 2024 · Wednesday, the drugmaker said it closed a $185 million deal to acquire Acorda Therapeutics’ inhaled Parkinson’s disease med Inbrija and its sustained release multiple …See details»
History - Merz Pharma
As a company with a long history, Merz has held different focus areas over the years. From dental products to Alzheimer’s disease breakthroughs, we have successfully reinvented ourselves …See details»
The patient in focus - vision & values | Merz Therapeutics
1-855-463-7989 [email protected]. Global Corporate development. More than 110 years of innovation. Better outcomes for more patients. ... is subject to the legal requirements …See details»
Products | Merz Therapeutics
Merz Therapeutics provides leading therapeutic treatment options for patients. Our focus on advancing neurotoxin technology has given way to a clinically-proven and time-tested therapy …See details»
Sustainability - Merz Therapeutics
Our Sustainability Strategy is based on an analysis of the most important issues for our business and developed in a way that benefits internal and external stakeholders. There are 4 …See details»